by Capecitabine is an orally-administered chemotherapeutic agent used in the treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil antimetabolite in the tumor, where it inhibits DNA synthesis and slows growth of tumor tissue.
The global Capecitabine market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Capecitabine by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Get More Information about this Report and TOC @ https://www.planetmarketreports.com/reports/global-capecitabine-market-5596
Product Type Coverage Market Size and Forecast, Major Company of Product Type etc. :
500 mg
150 mg
Company Coverage Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc. :
Teva
Roche
Mylan
Hikma
Hengrui Medicine
Cipla
Reliance Group
Hetero
Application Coverage Market Size and Forecast, Different Demand Market by Region, Main Consumer Profile etc. :
Breast Cancer
Colorectal cancer
Stomach Cancer
Region Coverage Regional Production, Demand and Forecast by Countries etc. :
North America U.S., Canada, Mexico
Europe Germany, U.K., France, Italy, Russia, Spain etc.
Asia-Pacific China, India, Japan, Southeast Asia etc.
South America Brazil, Argentina etc.
Middle East and Africa Saudi Arabia, South Africa etc
